Instructions to Authors

Azerbaijan Journal of Hematology is the scientific, peer-reviewed, open-access journal of the Azerbaijan Hematology Specialists Association. The journal comprises three issues as April, August, December in a volume. The journal’s publication language is English.

The journal aims to publish scientifically high quality articles which can contribute to the literature and written in the emergency medicine field and other related fields. Review articles, case reports, editorial comments, letters to the editor, scientific letters, education articles, original images and articles on history and publication ethics which can contribute to readers and medical education are also published.

Manuscripts should be prepared according to ICMJE guidelines. Original manuscripts require a structured abstract. Label each section of the structured abstract with the appropriate subheading (Objective, Materials and Methods, Results, and Conclusion). Letters to the editor do not require an abstract. Research or project support should be acknowledged as a footnote on the title page. Technical and other assistance should be provided on the title page.

Submissions and publication are free of charge.

The journal’s target audience includes general practitioners interested in hematology and internal medicine specialists.


The editorial and publication processes of the journal are shaped in accordance with the guidelines of the International Committee of Medical Journal Editors (ICMJE), World Association of Medical Editors (WAME), Council of Science Editors (CSE), Committee on Publication Ethics (COPE), European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal is in conformity with the Principles of Transparency and Best Practice in Scholarly Publishing.

Originality, high scientific quality, and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or already published in an electronic or printed medium. The journal should be informed of manuscripts that have been submitted to another journal for evaluation and rejected for publication. The submission of previous reviewer reports will expedite the evaluation process. Manuscripts presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization.


Manuscripts submitted to the Azerbaijan Journal of Hematology will go through a double-blind peer-review process. Each submission will be reviewed by peer reviewers who are experts in their fields in order to ensure an unbiased evaluation process. The Editor in Chief is the final authority in the decision-making process for all submissions. For more detailed information, please read Ethical Policy page of the Journal.


The Azerbaijan Journal of Hematology requires and encourages the authors and the individuals involved in the evaluation process of submitted manuscripts to disclose any existing or potential conflicts of interests, including financial, consultant, and institutional, that might lead to potential bias or a conflict of interest. Any financial grants or other support received for a submitted study from individuals or institutions should be disclosed to the Editorial Board. To disclose a potential conflict of interest, the ICMJE Potential Conflict of Interest Disclosure Form should be filled in and submitted by all contributing authors. The journal’s Editorial Board resolves cases of a potential conflict of interest of the editors, authors, or reviewers within the scope of COPE and ICMJE guidelines.


The Editorial Board of the journal handles all appeal and complaint cases within the scope of COPE guidelines. In such cases, authors should get in direct contact with the editorial office regarding their appeals and complaints. When needed, an ombudsperson may be assigned to resolve claims that cannot be resolved internally. The Editor in Chief is the final authority in the decision-making process for all appeals and complaints.


By signing the Copyright License Agreement, authors retain the copyright of their work and agree that the article, if accepted for publication by the Azerbaijan Journal of Hematology will be licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).

A Creative Commons license is a public copyright license that provides free distribution of copyrighted works or studies. Authors use the CC license to transfer the right to use, share or modify their work to third parties.

Open access is an approach that supports interdisciplinary development and encourages collaboration between different disciplines. Therefore, the Azerbaijan Journal of Hematology contributes to the scientific publishing literature by providing more access to its articles and a more transparent review process.


Statements or opinions expressed in the manuscripts published in the Azerbaijan Journal of Hematology reflect the views of the author(s) and not the opinions of the editors, the editorial board, or the publisher; the editors, the editorial board, and the publisher disclaim any responsibility or liability for such materials. The final responsibility regarding the published content rests with the authors.


◙ Cover Letter,

◙ ICMJE Conflict of Interest Statement Form for all contributing authors,

◙ A separate title page (Title Page should be submitted with all manuscripts and should include the title of the manuscript, name(s), affiliation(s), major degree(s) and ORCID ID of the author(s). The name, address, telephone (including the mobile phone number) and fax numbers and e-mail address of the corresponding author should be clearly listed. Grant information and other sources of support should also be included. Individuals who contributed to the preparation of the manuscript but did not fulfil the authorship criteria should also be acknowledged on the title page),

◙ Abstract divided into appropriate sections,

◙ Keywords (For indexing purposes, a list of 4–8 keywords in English is essential),

◙ Article divided into appropriate sections,

◙ List of references styled according to “journal requirements”,

◙ A blinded main text (Please exclude all information that may indicate an individual or institution from the main document to ensure a blinded review process),

◙ The Copyright Agreement and Acknowledgement of Authorship Form (Please submit a wet-signed and scanned copy of the Copyright Transfer Form with your submission),

◙ Upload your title page and forms in the system to the Potential Conflict of Interest category to ensure a blinded review process,

◙ Figures (Figures should be submitted as standalone images through the submission system in .JPG or .TIFF format),

◙ Ethics Committee Approval Statement (with decision/file no, date and name of the institution, for original articles).


The manuscripts should be prepared in accordance with ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. Authors are required to

The presentation of the article types must be designed in accordance with trial reporting guidelines:

Human research: Helsinki Declaration as revised in 2013

Systematic reviews and meta-analyses: PRISMA guidelines

Case reports: the CARE case report guidelines

Clinical trials: CONSORT

Animal studies: ARRIVE and Guide for the Care and Use of Laboratory Animals

Diagnostic accuracy: STARD Guidelines

Non-randomized public behaviour: TREND

Manuscripts can only be submitted through the journal’s online manuscript submission and evaluation system, available at Manuscripts submitted via any other medium and submissions by anyone other than one of the authors will not be evaluated.

Authors are required to submit the following:

Copyright Agreement and Acknowledgement of Authorship Form

ICMJE Potential Conflict of Interest Disclosure Form (should be filled in by all contributing authors) during the initial submission. These forms are available for download at com/.

Preparation of the Manuscript

Title page: A separate title page should be submitted with all submissions and this page should include;

  • The full title of the manuscript as well as a short title (running head) of no more than 50 characters,
  • Name(s), affiliations and major degree(s) of the author(s)
  • Grant information and detailed information on the other sources of support,
  • The name, address, telephone (including the mobile phone number) and fax numbers and e-mail address of the corresponding author,
  • Acknowledgement of the individuals who contributed to the preparation of the manuscript but do not fulfil the authorship criteria.

Abstract: An abstract should be submitted with all submissions except for letters to the editor. The abstract of Original Articles should be structured with subheadings (Aim, Materials and Method, Results and Conclusion). For Azerbaijani authors, the abstract should be in Azerbaijani-English. Non-Azerbaijani authors are not required to submit an abstract in Azerbaijani.

Keywords: Each submission must be accompanied by a minimum of three and a maximum of six keywords for subject indexing at the end of the abstract. The keywords should be listed in full without abbreviations.

Running Head: The running head should not be more than 40 characters, including spaces, and should be located at the bottom of the title page.

Word Count: A word count for the manuscript, excluding abstract, acknowledgments, figure and table legends, and references, should be provided not exceed 2500 words. The word count for an abstract should be not exceed 300 words.

Materials and Methods: Important methods should be written respectively.

Conclusion: The study’s new and important findings should be highlighted and interpreted.

Other types of manuscripts, such as reviews, perspectives, and editorials, will be published according to uniform requirements. Provide 3-10 keywords below the abstract to assist indexers. Use terms from the Index Medicus Medical Subject Headings List.

(for randomized studies a CONSORT abstract should be provided (

Introduction: The introduction should include an overview of the relevant literature presented in summary form (one page), and what ever remains interesting, unique, problematic, relevant, or unknown about the topic must be specified. The introduction should conclude with the rationale for the study, its design, and its objective(s).

Materials and Methods: Clearly describe the selection of observational or experimental participants, such as patients, laboratory animals, and controls, including inclusion and exclusion criteria and a description of the source population. Identify the methods and procedures in sufficient detail to allow other researchers to reproduce your results. Provide references to established methods (including statistical methods), provide references to brief modified methods, and provide the rationale for using them and an evaluation of their limitations. Identify all drugs and chemicals used, including generic names, doses, and routes of administration. The section should include only information that was available at the time the plan or protocol for the study was devised (

Statistics: Describe the statistical methods used in enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. Statistically important data should be given in the text, tables and figures. Provide details about randomization, describe treatment complications, provide the number of observations, and specify all computer programs used.

Results: Present your results in logical sequence in the text, tables, and figures. Do not present all the data provided in the tables and/or figures in the text; emphasize and/or summarize only important findings, results, and observations in the text. For clinical studies provide the number of samples, cases, and controls included in the study. Discrepancies between the planned number and obtained number of participants should be explained. Comparisons, and statistically important values (i.e. P value and confidence interval) should be provided.

Discussion: This section should include a discussion of the data. New and important findings/results, and the conclusions they lead to should be emphasized. Link the conclusions with the goals of the study, but avoid unqualified statements and conclusions not completely supported by the data. Do not repeat the findings/results in detail; important findings/results should be compared with those of similar studies in the literature, along with a summarization. In other words, similarities or differences in the obtained findings/results with those previously reported should be discussed.

Study Limitations: Limitations of the study should be detailed. In addition, an evaluation of the implications of the obtained findings/results for future research should be outlined.

Manuscript Types

Original Articles: This is the most important type of article since it provides new information based on original research. The main text of original articles should be structured with Introduction, Materials and Methods (with subheadings), Results, Discussion, Study Limitations, Conclusion subheadings. Please check Table 1 for limitations for Original Articles.

Statistical analysis to support conclusions is usually necessary. Statistical analyses must be conducted in accordance with the international statistical reporting standards (Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J 1983:7;1489-93). Information on statistical analyses should be provided with a separate subheading under the Materials and Methods section and statistical software that was used the process must certainly be specified. Data must be expressed as mean±standard deviation when parametric tests are used to compare continuous variables. Data must be expressed as median (minimum-maximum) and percentiles (25th and 75th percentiles) when non-parametric tests are used. In advanced and complicated statistical analyses, relative risk (RR), odds ratio (OR) and hazard ratio (HR) must be supported by confidence intervals (CI) and p values.

Editorial Comments: Editorial comments aim at providing brief critical commentary by the reviewers having expertise or with high reputation on the topic of the research article published in the journal. Authors are selected and invited by the journal. Abstract, Keywords, Tables, Figures, Images and other media are not included.

Review Articles: Reviews which are prepared by authors who have extensive knowledge on a particular field and whose scientific background has been translated into high volume of publication and higher citation potential are taken under review. The authors may be invited by the journal. Reviews should be describing, discussing and evaluating the current level of knowledge or topic used in the clinical practice and should guide future studies. Please check Table 1 for limitations for Review Articles.

Case Reports: There is limited space for case reports in the journal and reports on rare cases or conditions that constitute challenges in the diagnosis and treatment, those offering new therapies or revealing knowledge not included in the books, and interesting and educative case reports are accepted for publication. The text should include Introduction, Case Report, Discussion, Conclusion subheadings. Please check Table 1 for limitations for Case Reports.

Letters to the Editor: This type of manuscripts can discuss important parts, overlooked aspects or lacking parts of a previously published article. Articles on the subjects within the scope of the journal that might attract the readers’ attention, particularly educative cases can also be submitted in the form of “Letter to the Editor”. Readers can also present their comments on the published manuscripts in the form of “Letter to the Editor”. Abstract, Keywords, Tables, Figures, Images and other media are not included. The text should be unstructured. The manuscript that is being commented on must be properly cited within the manuscript.

Scientific letter: Manuscripts with prior notification characteristics, announcing new, clinically important scientific developments or information are accepted as Scientific Letters. Scientific Letters should not include sub-headings and should not exceed 900 words. Number of references should be limited to 10 and number of tables and figures should be limited to 2.

Clinical Imaging Visual Diagnosis: Images must be typical for diagnosis, and should facilitate rapid diagnosis for emergency medicine and / or should be educational. Except for the header and references, it must consist of maximum 400 words. A maximum of three authors name, six images and five refecences should be included.

History: This type of manuscript explains events related to emergency and general medicine and presents information on the history of diagnosis and treatment of diseases. Historical findings should be a result of relevant research studies. Manuscript should not include sub-headings, should not exceed 900 words and total number of references should be limited to 10.


Tables should be included in the main document, presented after the reference list and they should be numbered consecutively in the order they are referred to within the main text. A descriptive title must be placed above the tables. Abbreviations used in the tables should be defined below the tables by footnotes (even if they are defined within the main text). Tables should be created using the “insert table” command of the word processing software and they should be arranged clearly to provide an easy reading. Data presented in the tables should not be a repetition of the data presented within the main text but should be supporting the main text.

Figures and Figure Legends

Figures, graphics and photographs should be submitted as separate files (in TIFF or JPEG format) through the submission system. The files should not be embedded in a Word document or the main document. When there are figure subunits, the subunits should not be merged to form a single image. Each subunit should be submitted separately through the submission system. Images should not be labelled (a, b, c, etc.) to indicate figure subunits. Thick and thin arrows, arrowheads, stars, asterisks and similar marks can be used on the images to support figure legends. Like the rest of the submission, the figures too should be blind. Any information within the images that may indicate an individual or institution should be blinded. The minimum resolution of each submitted figure should be 300DPI. To prevent delays in the evaluation process all submitted figures should be clear in resolution and large in size (minimum dimensions 100x100 mm). Figure legends should be listed at the end of the main document.

All acronyms and abbreviations used in the manuscript should be defined at first use, both in the abstract and the main text. The abbreviation should be provided in parenthesis following the definition.

When a drug, product, hardware, or software mentioned within the main text product information, including the name of the product, producer of the product, city of the company and the country of the company should be provided in parenthesis in the following format: “Discovery St PET/CT scanner (General Electric, Milwaukee, WI, USA)”

All references, tables and figures should be referred to within the main text and they should be numbered consecutively in the order they are referred to within the main text.

Limitations, drawbacks and shortcomings of original articles should be mentioned in the “Discussion” section before the conclusion paragraph.


While citing publications, preference should be given to the latest, most up to date publications. If an ahead of print publication is being cited the DOI number should be provided. Authors are responsible for the accuracy of references. Journal titles should be abbreviated in accordance with the journal abbreviations in Index Medicus/ Medline/PubMed (for journal abbreviations consult the List of Journals indexed for MEDLINE, published annually by NLM). When there are 6 or fewer authors, all authors should be listed. If there are 7 or more authors the first 6 authors should be listed followed by “et al.”. In the main text, references should be cited as open source [1,2,3,4] in parenthesis numbers. The reference styles for different types of publications are presented in the following examples:

Journal article: Lewin MR, Stein J, Wang R, Lee MM, Kernberg M, Boukhman M, et al. Humming is as effective as Valsalva’s maneuver and Trendelenburg’s position for ultrasonographic visualization of the jugular venous system and common femoral veins. Ann Emerg Med. 2007;50:73-7.

Book Section: Sherry S. Detection of thrombi. In: Strauss HE, Pitt B, James AE, editors. Cardiovascular Medicine. St Louis: Mosby; 1974.p.273-85.

Books with Single Author: Cohn PF. Silent myocardial ischemia and infarction. 3rd ed. New York: Marcel Dekker; 1993.

Editor(s) as author: Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 1996.

Conference Proceedings: Bengisson S. Sothemin BG. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, editors. MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sept 6-10; Geneva, Switzerland. Amsterdam: North-Holland; 1992.p.1561-5.

Scientific or Technical Report: Smith P. Golladay K. Payment for durable medical equipment billed during skilled nursing facility stays. Final report. Dallas (TX) Dept. of Health and Human Services (US). Office of Evaluation and Inspections: 1994 Oct. Report No: HHSIGOE 169200860.

Thesis: Kaplan SI. Post-hospital home health care: the elderly access and utilization (dissertation). St. Louis (MO): Washington Univ. 1995.

Manuscripts accepted for publication, not published yet: Leshner AI. Molecular mechanisms of cocaine addiction. N Engl J Med In press 1997.

Epub ahead of print Articles: Aksu HU, Ertürk M, Gül M, Uslu N. Successful treatment of a patient with pulmonary embolism and biatrial thrombus. Anadolu Kardiyol Derg 2012 Dec 26. doi: 10.5152/akd.2013.062. [Epub ahead of print]

Manuscripts published in electronic format: Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis (serial online) 1995 Jan-Mar (cited 1996 June 5): 1(1): (24 screens). Available from: URL:


When submitting a revised version of a paper, the author must submit a detailed “Response to the reviewers” that states point by point how each issue raised by the reviewers has been covered and where it can be found (each reviewer’s comment, followed by the author’s reply and line numbers where the changes have been made) as well as an annotated copy of the main document. Revised manuscripts must be submitted within 30 days from the date of the decision letter. If the revised version of the manuscript is not submitted within the allocated time, the revision option may be cancelled. If the submitting author(s) believe that additional time is required, they should request this extension before the initial 30-day period is over.

Accepted manuscripts are copy-edited for grammar, punctuation, and format. Once the publication process of a manuscript is completed, it is published online on the journal’s webpage as an ahead-of-print publication before it is included in its scheduled issue. A PDF proof of the accepted manuscript is sent to the corresponding author, and their publication approval is requested within two days of their receipt of the proof.


Out of respect to the reviewers, journal staff and the Editorial Board, authors are asked to submit a withdrawal request only if the reasons are compelling and unavoidable. Withdrawal requests should be submitted in written form, signed by all contributing authors of the manuscript. Reasons for withdrawal should be stated clearly. Each request will be subject to the Editorial Board's review and manuscripts will only be assumed withdrawn upon Editorial Board's approval. Cases of plagiarism, authorship disputes or fraudulent use of data will be handled in accordance with COPE guidelines.


Publisher: Galenos Yayınevi
Address:  Molla Gürani Mah. Kaçamak Sok. 21/1 Fındıkzade, Fatih, Istanbul, Turkey
Phone:  +90 212 621 99 27
Fax: +90 212 217 22 92
E-mail: [email protected]

About Journal


Useful Links